The Avoca Group announced today that David Shing, Verizon Media’s
Digital Prophet, will deliver the keynote address at the 8th
Annual Avoca Global Summit. David will discuss current and future trends
in the evolving digital landscape, including how rapid adoption of
technology will advance the work of the clinical trials industry. He
will also provide insight into what the industry’s most valued
stakeholder, the patient, will expect from clinical trials.
“We’re excited to have David Shing set the stage for the second day of
the 8th Annual Avoca Global Summit,” says Patricia Leuchten, Founder and
CEO, The Avoca Group. “Technology and digitization play a vital role in
drug development, particularly in how we plan, execute, and oversee
clinical trials. A broader view of how technology is evolving will help
us to put both the opportunities and the challenges ahead into a broader
perspective.”
The 8th Annual Avoca Global Summit will be held June 5-6 at
the Boston Harbor Hotel in Boston, MA. With over a dozen interactive
sessions and numerous networking opportunities, the Summit offers
attendees the chance to connect, address challenges, engage with thought
leaders, and influence global change in the execution of clinical
trials. The collaborative nature of the event allows for the free flow
of ideas required to view the important work of clinical research
through a diverse lens. An estimated 150 people, including C-suite
executives, heads of clinical operations, quality, regulatory,
procurement, and innovation, are expected to attend. For the first time,
The Summit will also include an Exhibit Hall featuring exhibitors
including Comprehend, KPS Life, Longboat, Oracle Health Sciences, and
Rho.
The current list of confirmed speakers includes (in alphabetical order):
- Chen Admati, Head of Intel Pharma Analytics Platform, Intel Corporation
-
Beatrice Anduze-Faris, MD, Executive Director, Head of Global Clinical
Compliance and Continuous Improvement, Global Clinical Operations,
Bristol-Myers Squibb -
Brian Burk, Life Science & Healthcare Innovation Practice Leader,
Verizon Media -
Bree Burks, Senior Director, Vanderbilt Institute for Clinical and
Translational Research, Vanderbilt University Medical Center - Jennifer Byrne, CEO and Board Chair, Javara
-
Patty Donnelly, PhD, Vice President, Global Quality – Research and
Development, Eli Lilly and Company -
Ken Getz, Director, Sponsored Research, Associate Professor, Tufts
CSDD, Tufts University School of Medicine -
Joseph Kim, Senior Advisor in Translational Technology and Innovation,
Eli Lilly and Company -
Lenna Kimball, MBA, Vice President, Clinical Operations, Lyell
Immunopharma -
Jim Kremidas, Executive Director, Association of Clinical Research
Professionals -
Elizabeth Luzcak, Vice President, Vertex Quality Assurance, Vertex
Pharmaceuticals - Tom Pike, Former CEO, Quintiles
-
Jonathan Rowe, PhD, MS, MA, Executive Director, Head of Clinical
Development Quality Performance and Risk Management, Pfizer - Paddy Wall, BSc, MBA, Senior Manager Strategic Partnerships, Longboat
Own the Future. Learn more about the 8th Annual Avoca Global
Summit at www.theavocagroup.com/quality-consortium/8th-annual-summit/.
About David Shing
David Shing, aka Shingy, is Verizon Media’s Digital Prophet. He spends
most of his time watching the future take shape across the vast online
landscape. The rest he spends talking to people about where things are
headed and how we can get the most out of it. Shing has spent most of
his adult life in the digital world working for both large and small
creative companies globally, while also co-authoring several
technology-related patents. He served as AOL’s European head of media
and marketing before taking on his current mantle in New York City.
About The Avoca Group
The Avoca Group leads the industry in GCP quality and compliance
solutions. With 20 years of experience providing research and consulting
services, Avoca merges deep institutional knowledge in the foundations
of good clinical practice with future-forward leadership in regulatory
compliance, quality management, and clinical operations across the
evolving clinical trials landscape. The Avoca Quality Consortium,
Avoca’s cross-functional collaborative, unites sponsors, CROs, and
clinical service providers to address challenges and maximize
opportunities to mitigate risk and improve quality in the execution of
clinical trials. To learn more about The Avoca Group’s products and
services, visit www.theavocagroup.com
or www.theavocagroup.com/consulting-research-services.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190509005666/en/